(Q44567807)

English

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

scientific article published in September 2003

Statements

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (English)
M J Moore
P D Eisenberg
M Dagenais
B Greenberg
B Colwell
J Ottaway
R Humphrey
L Seymour
1 September 2003
3296-3302

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit